Newswise — WASHINGTON, D.C. (May 6, 2015) — Winner of the Leksell Radiosurgery Award, Deborah C. Marshall, recently presented her research, Survival Patterns of Patients with Cerebral Metastases after Multiple Rounds of Stereotactic Radiosurgery (SRS), at the 2015 American Association of Neurological Surgeons Annual Scientific Meeting.

With escalating focus on cost containment, there is increasing scrutiny on the practice of multiple rounds of SRS for patients suffering from subsequent brain metastases distant to the initial site. A major concern is that such recurrence may be a prognostic indicator of poor overall survival.

This study retrospectively analyzed outcomes of 801 patients with 3,683 brain metastases from primary breast, colorectal, lung, melanoma and renal cancers consecutively treated at the University of California, San Diego/San Diego Gamma Knife Center (UCSD/SDGKC), comparing the survival pattern of patients who underwent a single round (n=643) versus multiple rounds (n=158) of SRS for subsequent brain metastases. Multivariate analyses were performed to control for known prognostic variables, including age, Karnofsky performance status, number of metastases, cumulative tumor volume and systemic disease status.

No significant difference in median survival from the time of final round of SRS was found for patients undergoing one, two, three or >four rounds of SRS (median survival of 167, 202, 129 and 127 days, respectively, p=0.49).

Median intervals between treatments consistently ranged from 140 to 178 days, irrespective of rounds of SRS (p=0.25). Patients who underwent multiple rounds of SRS tended to be younger, have achieved systemic disease control, harbor lower cumulative tumor volume but have an increased number of metastases (p-values <0.001, <0.001, <0.001 and 0.02, respectively). Multivariate analysis of pertinent clinical variables revealed that additional rounds of SRS did not significantly influence overall survival (p<0.001).

For judiciously selected patients, median overall survival was comparable for brain metastases patients who underwent single or multiple rounds of SRS. The decision of whole brain radiation therapy (WBRT) versus multi-round SRS should be tailored to the clinical condition of patient based on judgment of the treating physician.

Author Block: Teddy Kim, MD; Steven Goetsch, PhD; John F. Alksne, MD, FAANS(L); Kenneth H. Ott, MD, FAANS; David Hodgens, MD; Bob S. Carter, MD, PhD, FAANS; Jona Hattangadi-Gluth, MD; Clark Chen, MD, PhD, FAANS.

Disclosure: The author reported no disclosures prior to the 83rd AANS Annual Scientific Meeting.

Media Representatives: The 2015 AANS Annual Scientific Meeting press kit includes releases on highlighted scientific research, AANS officers and award winners, Neurosurgery Awareness Week and other relevant information about this year’s program. Those releases will also be posted under the “Media” area on the 2015 AANS Annual Scientific Meeting website. If you have interest in a topic related to neurosurgery or would like to interview a neurosurgeon — either onsite or via telephone — during this year’s event, please contact Alice Kelsey, AANS director of marketing and communications, via email at [email protected].

About the 2015 AANS Annual Scientific Meeting: Attended by neurosurgeons, neurosurgical residents, medical students, neuroscience nurses, clinical specialists, physician assistants, allied health professionals and other medical professionals, the AANS Annual Scientific Meeting is the largest gathering of neurosurgeons in the nation, with an emphasis on the field’s latest research and technological advances. More than 1,200 scientific abstracts were presented for review at the 2015 AANS Annual Scientific Meeting, and the scientific presentations given at this year’s event represent cutting-edge examples of the incredible developments taking place within the field of neurosurgery. Additional information about the 2015 AANS Annual Scientific Meeting and the meeting program can be found here.

Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 9,000 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. Fellows of the AANS are board-certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons of Canada, or the Mexican Council of Neurological Surgery, A.C. Neurosurgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the spinal column, spinal cord, brain, nervous system and peripheral nerves.

For more information, visit www.AANS.org.

###

Meeting Link: AANS Annual Meeting, May-2015